Cargando…

A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction

AIMS: Global longitudinal strain (GLS) has become an alternative to left ventricular ejection fraction (LVEF) to determine systolic function of the heart. The absence of cut‐off values is one of the limitations preventing full clinical implementation. The aim of this study is to determine a cut‐off...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdonschot, Job A.J., Henkens, Michiel T.H.M., Wang, Ping, Schummers, Georg, Raafs, Anne G., Krapels, Ingrid P.C., van Empel, Vanessa, Heymans, Stephane R.B., Brunner‐La Rocca, Hans‐Peter, Knackstedt, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497344/
https://www.ncbi.nlm.nih.gov/pubmed/34272829
http://dx.doi.org/10.1002/ehf2.13465
_version_ 1784579940676534272
author Verdonschot, Job A.J.
Henkens, Michiel T.H.M.
Wang, Ping
Schummers, Georg
Raafs, Anne G.
Krapels, Ingrid P.C.
van Empel, Vanessa
Heymans, Stephane R.B.
Brunner‐La Rocca, Hans‐Peter
Knackstedt, Christian
author_facet Verdonschot, Job A.J.
Henkens, Michiel T.H.M.
Wang, Ping
Schummers, Georg
Raafs, Anne G.
Krapels, Ingrid P.C.
van Empel, Vanessa
Heymans, Stephane R.B.
Brunner‐La Rocca, Hans‐Peter
Knackstedt, Christian
author_sort Verdonschot, Job A.J.
collection PubMed
description AIMS: Global longitudinal strain (GLS) has become an alternative to left ventricular ejection fraction (LVEF) to determine systolic function of the heart. The absence of cut‐off values is one of the limitations preventing full clinical implementation. The aim of this study is to determine a cut‐off value of GLS for an increased risk of adverse events in individuals with a normal LVEF. METHODS AND RESULTS: Echocardiographic images of 502 subjects (52% female, mean age 48 ± 15) with an LVEF ≥ 55% were analysed using speckle tracking‐based GLS. The primary endpoint was cardiovascular death or cardiac hospitalization. The analysis of Cox models with splines was performed to visualize the effect of GLS on outcome. A cut‐off value was suggested by determining the optimal specificity and sensitivity. The median GLS was −22.2% (inter‐quartile range −20.0 to −24.9%). In total, 35 subjects (7%) had a cardiac hospitalization and/or died because of cardiovascular disease during a follow‐up of 40 (5–80) months. There was a linear correlation between the risk for adverse events and GLS value. Subjects with a normal LVEF and a GLS between −22.9% and −20.9% had a mildly increased risk (hazard ratio 1.01–2.0) for cardiac hospitalization or cardiovascular mortality, and the risk was doubled for subjects with a GLS of −20.9% and higher. The optimal specificity and sensitivity were determined at a GLS value of −20.0% (hazard ratio 2.49; 95% confidence interval: 1.71–3.61). CONCLUSIONS: There is a strong correlation between cardiac adverse events and GLS values in subjects with a normal LVEF. In our single‐centre study, −20.0% was determined as a cut‐off value to identify subjects at risk. A next step should be to integrate GLS values in a multi‐parametric model.
format Online
Article
Text
id pubmed-8497344
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84973442021-10-12 A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction Verdonschot, Job A.J. Henkens, Michiel T.H.M. Wang, Ping Schummers, Georg Raafs, Anne G. Krapels, Ingrid P.C. van Empel, Vanessa Heymans, Stephane R.B. Brunner‐La Rocca, Hans‐Peter Knackstedt, Christian ESC Heart Fail Short Communications AIMS: Global longitudinal strain (GLS) has become an alternative to left ventricular ejection fraction (LVEF) to determine systolic function of the heart. The absence of cut‐off values is one of the limitations preventing full clinical implementation. The aim of this study is to determine a cut‐off value of GLS for an increased risk of adverse events in individuals with a normal LVEF. METHODS AND RESULTS: Echocardiographic images of 502 subjects (52% female, mean age 48 ± 15) with an LVEF ≥ 55% were analysed using speckle tracking‐based GLS. The primary endpoint was cardiovascular death or cardiac hospitalization. The analysis of Cox models with splines was performed to visualize the effect of GLS on outcome. A cut‐off value was suggested by determining the optimal specificity and sensitivity. The median GLS was −22.2% (inter‐quartile range −20.0 to −24.9%). In total, 35 subjects (7%) had a cardiac hospitalization and/or died because of cardiovascular disease during a follow‐up of 40 (5–80) months. There was a linear correlation between the risk for adverse events and GLS value. Subjects with a normal LVEF and a GLS between −22.9% and −20.9% had a mildly increased risk (hazard ratio 1.01–2.0) for cardiac hospitalization or cardiovascular mortality, and the risk was doubled for subjects with a GLS of −20.9% and higher. The optimal specificity and sensitivity were determined at a GLS value of −20.0% (hazard ratio 2.49; 95% confidence interval: 1.71–3.61). CONCLUSIONS: There is a strong correlation between cardiac adverse events and GLS values in subjects with a normal LVEF. In our single‐centre study, −20.0% was determined as a cut‐off value to identify subjects at risk. A next step should be to integrate GLS values in a multi‐parametric model. John Wiley and Sons Inc. 2021-07-17 /pmc/articles/PMC8497344/ /pubmed/34272829 http://dx.doi.org/10.1002/ehf2.13465 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Short Communications
Verdonschot, Job A.J.
Henkens, Michiel T.H.M.
Wang, Ping
Schummers, Georg
Raafs, Anne G.
Krapels, Ingrid P.C.
van Empel, Vanessa
Heymans, Stephane R.B.
Brunner‐La Rocca, Hans‐Peter
Knackstedt, Christian
A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
title A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
title_full A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
title_fullStr A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
title_full_unstemmed A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
title_short A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
title_sort global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497344/
https://www.ncbi.nlm.nih.gov/pubmed/34272829
http://dx.doi.org/10.1002/ehf2.13465
work_keys_str_mv AT verdonschotjobaj agloballongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT henkensmichielthm agloballongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT wangping agloballongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT schummersgeorg agloballongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT raafsanneg agloballongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT krapelsingridpc agloballongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT vanempelvanessa agloballongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT heymansstephanerb agloballongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT brunnerlaroccahanspeter agloballongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT knackstedtchristian agloballongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT verdonschotjobaj globallongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT henkensmichielthm globallongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT wangping globallongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT schummersgeorg globallongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT raafsanneg globallongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT krapelsingridpc globallongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT vanempelvanessa globallongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT heymansstephanerb globallongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT brunnerlaroccahanspeter globallongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction
AT knackstedtchristian globallongitudinalstraincutoffvaluetopredictadverseoutcomesinindividualswithanormalejectionfraction